| 108.34 Delayed Data As of 4:03pm ET |  +1.25 / +1.17%Today’s Change | 88.17 Today|||52-Week Range 132.13 | -6.38% Year-to-Date |
| Previous close | 107.09 |
| Today’s open | 107.83 |
| Day’s range | 107.24 - 108.48 |
| Volume | 3,232,898 |
| Average volume (3 months) | 7,268,984 |
| Market cap | $105.1B |
| Earnings growth (last year) | -- |
| Earnings growth (this year) | +2.21% |
| Earnings growth (next 5 years) | +9.18% |
| Revenue growth (last year) | +7.36% |
| P/E ratio | 41.8 |
| Price/Sales | 4.87 |
| Price/Book | 11.65 |
| Today’s change | Today’s % change | |
|---|---|---|
| SNYSanofi | +0.38 | +0.91% |
| GSKGlaxoSmithKline | +0.27 | +0.66% |
| AZNAstraZeneca | +0.39 | +0.97% |
| ABBVAbbVie | -0.07 | -0.10% |
| Next reporting date | July 30, 2019 |
| EPS forecast (this quarter) | $1.45 |
| Annual revenue (last year) | $24.6B |
| Annual profit (last year) | $3.2B |
| Net profit margin | 13.16% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
Chairman, President & Chief Executive Officer David A. Ricks |
Senior VP & President-Manufacturing Operations Myles Oneill |
Corporate headquarters Indianapolis, Indiana |
